Researchers report 3 percent annual rise in intermediate- and high-risk cases
The pioneering prostate cancer drug abiraterone can significantly extend the lives of men with advanced prostate cancer if administered prior to administering chemotherapy, according to phase III clinical trial data.
New research suggests that active surveillance may be an initial approach for men with favorable intermediate-risk prostate cancer.
A recent study has determined that radiation therapy is the most common treatment for prostate cancer regardless of cancer stage, PSA level, or prognosis and risk rating.
Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.
Black men are less willing to be investigated for prostate cancer, thereby increasing the likelihood of being diagnosed.
When active surveillance is chosen, survival for intermediate-risk disease may be decreased.
Individuals who've had testicular cancer may be at increased risk for prostate cancer, but the overall risk is low, according to a study.
Most common treatment for prostate cancer is radiation therapy, regardless of cancer stage.
Variation was observed at a high-volume center when surgeons selected patients with low-risk prostate cancer to undergo radical prostatectomy, according to a study.
Low doses of metformin and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors.
From 2004 to 2009, marked increase in observation among men with low-risk prostate cancer has been observed.
Guideline outlines recommended follow-up care for prostate cancer survivors
Smoking is associated with an increased risk of breast cancer, prostate cancer, and routine infections.
Targeted magnetic resonance (MR)/ultrasound fusion biopsy outperformed standard biopsy technique for increased detection of high-risk prostate cancer, according to a recent study.
Researchers identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
Abiraterone significantly extends survival in men with advanced prostate cancer (PCa) if administered before chemotherapy.
Researchers have identified two genes that appear to be simultaneously overexpressed in aggressive prostate cancers resistant to the androgen-targeted treatments enzalutamide and abiraterone acetate.
Phosphodiesterase type 5 inhibitors up the risk of biochemical recurrence after radical prostatectomy, according to a recent study.
Prostate biopsies that combine both magnetic resonance imaging (MRI) technology and ultrasound appear to give more accurate results, according to a new study.
Former, as well as current, smokers saw higher risk for disease recurrence and radiation therapy-related urinary side effects.
Taking phosphodiesterase type 5 inhibitors following radical prostatectomy is associated with an elevated risk of recurrence.
Recent study confirmed the effects on smoking on patients with prostate cancer.
Examining more distant relations for prostate cancer can provide important patient history.
Study examines vaccine therapy in prostate cancer with rising prostate-specific antigen (PSA) levels
A vaccine therapy designed to boost the body's immune response may join available early treatment options for prostate cancer.
Focusing screening efforts on those with a positive family history of prostate cancer could be more effective.
The addition of radiation treatment to hormone therapy reduced more cancer deaths among older men locally advanced prostate cancer, compared to hormone therapy alone.
How men perceive their role within their family dynamic or social circles may impact how they respond to a cancer diagnosis. Often they retreat or shut down, further challenging the efforts of their oncology care providers and loved ones to help them cope.
A man's second-, third-degree relatives may be as significant as looking at his first-degree relatives to determine risk for developing prostate cancer.
Green tea may have a role a in the prevention and treatment of prostate cancer and other prostate conditions like prostatitis.
More than half of prostate cancer patients age 66 years and older have life expectancies of less than 10 years, yet half of them were over-treated for their prostate cancer with surgery, radiation, or brachytherapy.
This study investigated the effect of physical activity after a prostate cancer diagnosis on both overall and prostate cancer-specific mortality in a large cohort.
Current evidence seems to indicated that withholding T therapy in hypogonadal men cannot be justified.
Although prostate cancer can be successfully treated in many men, if the disease metastasizes to the bone, it is eventually lethal.
A recent meta-analysis demonstrated an association between aspirin and a reduced risk of prostate cancer.
The anticancer drug galeterone has proved successful in lowering prostate-specific antigen levels in men with castration-resistant prostate cancer (CRPC).
Men receiving hormone therapy for prostate cancer may be missing out on protective meds, researchers say.
A new anticancer drug, already in clinical development, may help spare healthy cells from the effects of radiation treatments.
A genetic test has been developed to identify which men are at higher risk for prostate cancer recurrence after localized treatment with surgery or radiotherapy.
Phosphorous is independently associated with the risk of developing lethal and high-grade prostate cancer.
Prostate cancer patients with hereditary mutations in the BRCA genes do not respond as well to conventional treatment such as surgery and radiotherapy, and they have a lower survival rate than patients who do not have these genetic mutations.
Olaparib, an experimental oral cancer drug, has shown an overall tumor response rate of 26% in advanced cancers associated with BRCA1 and BRCA2 mutations, according to recent research.
A new technique that employs advanced MRI scans to diagnose prostate cancer is being tested in a nationwide trial.
Metformin use associated with decreased risk of prostate cancer diagnosis while other oral antihyperglycemics had no decreased risk.
Less than 20 percent of top-ranked health sites advise against screening for prostate cancer, a recommendation made by the USPSTF.
Active surveillance allows men with prostate cancer to delay or avoid the side effects of its treatment as well.
A video-based educational tool increased comprehension of prostate health terms in patients with a mean literacy level of 7th grade or higher.
Molecular tests are poised to become a part of the treatment guidelines for prostate cancer. These tests provide information that extends beyond just identifying the type of cancer a patient has; they can also help narrow down treatment options to those that offer the best outcomes for patients.
Some prostate cancer medications are linked to an increased risk of dying from heart-related causes in men with congestive heart failure or with a history of prior heart attacks.
The endorsed guideline outlines use of adjuvant and salvage radiotherapy after surgery for prostate cancer.
Androgen deprivation therapy may increase risk of cardiac-related death in patients with cardiac issues
Men who were treated with androgen deprivation therapy for prostate cancer have a three times increased risk of cardiac problems.
Even a small daily dose of aspirin may help lower mortality among men with nonmetastatic prostate cancer, according to research.
Consuming 10 portions of tomatoes a week can reduce risk for developing prostate cancer by 18%.
Primary androgen deprivation therapy (PADT) was linked with increased all-cause mortality and prostate cancer-specific mortality.
For patients with low-risk prostate cancer managed with active surveillance, obesity may increase risk of progression
Obesity is linked with increased risk of progression of low-risk prostate cancers in active surveillance.
For some men, prostate cancer recurrence may be overdetected, especially in those aged over 70.
Researchers sought to determine which types of patients die from prostate cancer in the modern era.
Some patients whose PSA levels become elevated after prostatectomy may die as a result of a cause unrelated to prostate cancer.
Findings suggest that elevated levels of cholesterol and triglycerides may be linked with greater risk of the prostate cancer recurrence, but normalization of blood fats may reduce risk.
The effect of guidelines recommending that elderly men should not be routinely screened for prostate cancer has been minimal at best, according to a new study.
High cholesterol may be associated with an increased risk for developing prostate cancer.
Testosterone increased the risk for developing prostate cancer in rats.
Aspirin and other other NSAIDs were associated with a decreased risk for developing an aggressive form of prostate cancer.
Frank dela Rama, a new member of the Oncology Nurse Advisor editorial board, talks about helping men with newly diagnosed prostate cancer learn about and prepare to cope with their disease.
Prostate cancer treatment controversy continues as study finds watchful waiting not enough for some men
An active controversy among oncologists concerns watchful waiting versus more active treatment for prostate cancer.
Researchers have discovered that men who are not well educated about their prostate cancer have a much more difficult time deciding on treatment options.
Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line, according to research.
Guidelines recommending clinicians not routinely screen elderly men for prostate cancer have had a minimal effect on practice.
High rates of preserved sexual function seen with combination beam plus brachytherapy for prostate cancer.
Shorter time to testosterone recovery with 18 versus 36 months androgen deprivation therapy.
Baldness in men at age 45 is linked with an elevated risk for developing aggressive prostate cancer.
For men with early-stage prostate cancer, watching waiting is not always the best course of action, especially for black patients.
Enzalutamide reduces skeletal-related events in men with advanced castration-resistant prostate cancer
Enzalutamide was found to decrease the risk of skeletal-related events in men with metastatic castration-resistant prostate cancer.
Recommendations are for men whose tumors have grown resistant to hormonal therapies were issued jointly by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) in Canada.
There has been widespread adoption in the United States of robot-assisted prostatectomy to treat prostate cancer in recent years.
African American men may not benefit from watchful waiting after being diagnosed with low-grade prostate cancer.
Researchers have designed a new, non-invasive technique to screen for prostate cancer.
For economically disadvantaged men with newly diagnosed prostate cancer, poor knowledge about prostate cancer is associated with increased decisional conflict.
Healthy men participating in the Prostate Cancer Prevention Trial who actively participate in all trial steps are most likely to undergo a biopsy at the end of the trial, according to recent research.
Researchers found that men who aren't well educated about prostate cancer have more difficulty making decisions.
Men who eat more than 10 portions of tomatoes each week have an 18% lower risk of developing prostate cancer.
A calculator to help men and their doctors assess the risk of prostate cancer has had a major upgrade to enhance men's and their physicians' understanding of a man's risk of prostate cancer.
Men without prostate cancer taking part in the trial who participate in other aspects are most likely to undergo a challenging biopsy.
Prostate-specific antigen (PSA) screening is associated with a lasting reduction in prostate cancer mortality, according to a study published online.
A genomic tool can help doctors and patients make a more informed decision on the need for radiation therapy after surgery for prostate cancer.
Men with diagnosed depressive disorders are less likely to pursue definitive treatment options for prostate cancer and more likely to have poorer outcomes.
Robot-assisted surgery to remove cancerous prostate glands is effective in controlling the disease for 10 years, according to a new study.
Although their lives eventually return to normal after treatment, some men have to cope with lingering effects of their treatment that affects their libido or sexual function. Daniel Watter, EdD, offers guidance tips to share with patients who are surviving prostate cancer that can help them through the recovery process.
Two independent trials have validated the performance of an epigenetic test that could provide physicians with a better tool to help eliminate unnecessary repeat prostate biopsies.
A study of people who were adopted identified genetics as the dominant risk factor in familial breast, prostate, and colorectal cancers.
Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer, according to a new study.
A research team from Japan found that 16-core biopsy has a slightly higher detection rate than 12-core biopsy.
Researchers found that cyclists who bike more may face a higher risk of prostate cancer, but not a greater chance of infertility or erectile dysfunction.
Rates of observation as management for low-risk prostate cancer vary widely, and primary ADT is not tied to better survival for men with localized prostate cancer.
Results of a new study show that robot-assisted surgery to remove cancerous prostate glands is effective in controlling the disease for 10 years.
Vasectomy is associated with an increased incidence of prostate cancer overall during extended follow-up, with an elevated risk seen for high-grade and lethal cancer.
Depressed men with a diagnosis of intermediate- or high-risk prostate cancer have worse overall outcomes.
Physicians who diagnosed low-risk prostate cancer had more influence over the decision to enter active surveillance than did the disease characteristics, according to a case review.
Key genetic variants may affect how cancer patients respond to radiation treatments, according to a new study.
Researchers searching for a target that would interfere with cancer metastasis identified a new suppressor of metastasis that may lead toward the development of more effective treatments for prostate cancer and other malignant solid tumors.
- Cancer survivors need not be excluded from advanced stage lung cancer trials
- Fried food consumption associated with increased risk for heart failure
- Focus groups identify support needs of patients who smoke
- Twitter smoking cessation program helps smokers quit
- ASTRO applauds CMS decision to cover annual screening for high-risk lung cancer patients
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|